Stocks in play: Kinaxis Inc.
Announced Vertex Pharmaceuticals Incorporated, a global biotechnology company headquartered in Boston, has selected Kinaxis® to improve its end-to-end planning and operations to reduce supply chain risk. Kinaxis Inc. shares T.KXS are trading up $0.68 at $84.62.